US Customs and Border Protection is paying General Dynamics to create prototype “quantum sensors,” to be used with an AI ...

By 2026, AI is entering a new phase - more challenging, more pragmatic, and far more large-scale. The market has shed its illusions, money is being counted more carefully, and companies are asking a ...

GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...